Dr. Nelson J. Chao
Overview
What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun.
Dr. Chao is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.
His clinical research consists of co-authoring 197 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Duke Hematologic Malignancies Clinic
The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as a Distinguished provider by MediFind in the treatment of Midline Lethal Granuloma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.
Duke Blood Cancer Center
Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of Midline Lethal Granuloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Chao isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Chao isDistinguished. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)
- Multiple MyelomaDr. Chao isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Castleman DiseaseDr. Chao isAdvanced. Learn about Castleman Disease.
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Experienced
- AgranulocytosisDr. Chao isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Chao isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Chao isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaDr. Chao isExperienced. Learn about B-Cell Lymphoma.
- Bone GraftDr. Chao isExperienced. Learn about Bone Graft.
- Bone Marrow AspirationDr. Chao isExperienced. Learn about Bone Marrow Aspiration.